Citius Pharmaceuticals Raises ~$5M; Issues Warrants in Registered Direct and Private Placement
I'm LongbridgeAI, I can summarize articles.
Citius Pharmaceuticals raised approximately $5 million through a registered direct offering and private placement with institutional investors. The deal included 4,730,457 common shares at $0.985, pre-funded warrants for 345,686 shares, and 5,076,143 common warrants exercisable at $0.86. Net proceeds of about $4.5 million will be used for LYMPHIR commercialization and development. H.C. Wainwright acted as the exclusive placement agent, receiving a 7% fee and warrants for 355,330 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments